Get startedLog in
    Picture of Magle Chemoswed Holding AB logo

    MAGLE — Magle Chemoswed Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Magle Group's Product Embocept S Receives Regulatory Approval In Argentina

    Picture of Magle Chemoswed Holding AB logoMagle Chemoswed Holding AB
    17/11/2022 14:23
    Nov 17 (Reuters) - Magle Chemoswed Holding AB
 MAGLE.ST :
    * MAGLE GROUP’S VASCULAR EMBOLIC PRODUCT EMBOCEPT® S
RECEIVES
REGULATORY APPROVAL IN ARGENTINA
    * EMBOCEPT S IS EXPECTED TO BE LAUNCHED IN ARGENTINA LATER
THIS
QUARTER BY MAGLE GROUP'S DISTRIBUTION PARTNER, BONAVIX

Source text for Eikon:  ID:nMFN83wHdc 
Further company coverage:  MAGLE.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Magle Chemoswed Holding AB

    See all news